Home LLY
374.76
  Price1.20%   +4.43
 
loading

Eli Lilly and Company (LLY) Latest News

Dec-04-22 12:29PM Dividend Champion, Contender, And Challenger Highlights: Week Of December 4Seeking Alpha
Dec-02-22 08:45AM 2 Unstoppable Stocks That Could Make You Richer in 2023 and BeyondThe Motley Fool
08:07AM 2 Healthcare Stocks That Could Help Your PortfolioThe Motley Fool
Dec-02-22 07:55AM Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study GoalZacks Investment Research
06:28AM Chinese cities announce further easing of COVID curbs, though police are still patrolling streets to stop protestsMarketWatch
Dec-02-22 06:09AM Nasdaq, S&P 500 Futures Nervously Flit Around Ahead Of November Payrolls Data: Will Numbers Support Market Expectations For Slower Rate Hikes?Benzinga
Dec-01-22 01:32AM Chinese cities announce further easing of COVID curbs, though police are still patrolling streets to stop protestsMarketWatch
11:31AM Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?Zacks Investment Research
Dec-01-22 08:09AM Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's DrugZacks Investment Research
Nov-30-22 02:15AM What to know about the Alzheimer’s drug data coming out this weekMarketWatch
10:06AM Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?The Motley Fool
Nov-30-22 08:53AM Biogen's (BIIB) Lecanemab Shows Benefit but With Side EffectsZacks Investment Research
Nov-29-22 07:47AM What to know about the Alzheimer’s drug data coming out this weekMarketWatch
12:42PM Biogen (BIIB) Down on Report of Death in Alzheimer's StudyZacks Investment Research
Nov-29-22 09:05AM What to know about the Alzheimer’s drug data coming out this weekMarketWatch
07:39AM What to know about the Alzheimer’s drug data coming out this weekMarketWatch
Nov-27-22 07:30AM Up 32% in 2022, Is Eli Lilly Stock Still a Buy?The Motley Fool
Nov-26-22 12:44PM Elon Musk teases three-color Twitter verification plan: 'We'll see how it goes' MarketWatch
Nov-25-22 10:56AM Elon Musk teases three-color Twitter verification plan: 'We'll see how it goes' MarketWatch
09:45AM Incyte (INCY) Outperforms YTD: Will the Momentum Continue?Zacks Investment Research
Nov-23-22 09:00AM Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research
Nov-21-22 12:24PM Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023?Zacks Investment Research
Nov-19-22 08:00AM Disney Wins at the Box Office, but Makes Investors NervousThe Motley Fool
Nov-18-22 02:22AM Eli Lilly Is Best-In-Class Growth, Says Analyst While Initiating CoverageBenzinga
11:58AM Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022Benzinga
Nov-18-22 10:03AM Analyst Ratings for Eli LillyBenzinga
09:03AM Expert Ratings for Eli LillyBenzinga
Nov-18-22 08:27AM Zacks Investment Ideas feature highlights: Eli LillyZacks Investment Research
08:03AM Where Eli Lilly Stands With AnalystsBenzinga
Nov-17-22 12:19PM How Markets Have Fared Under a Divided CongressZacks Investment Research
08:37AM 3 Reasons Eli Lilly Is an Unstoppable StockThe Motley Fool
Nov-16-22 02:17AM After Rallying 50% in the Last 2 Months, Is Biogen Stock Still a Buy?Investing.com
10:23AM 2 Stocks That Could Outperform the Next Bull MarketThe Motley Fool
Nov-16-22 08:46AM Eli Lilly (LLY) Stock Up 26.7% YTD: What's in Store for 2023?Zacks Investment Research
Nov-15-22 05:04AM Successful Alzheimer's Data Would Have Placed Roche At Two-Year Competitive AdvantageBenzinga
09:55AM Roche (RHHBY) AD Study Failure Puts Spotlight on BIIB & OthersZacks Investment Research
Nov-15-22 07:14AM One Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatmentsMarketWatch
06:20AM Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?Zacks Investment Research
Nov-15-22 06:14AM The Zacks Analyst Blog Highlights Chevron, Eli Lilly, Charles Schwab, Salesforce and SAPZacks Investment Research
05:52AM Is Eli Lilly Stock a Buy After Last Week's Twitter Prank?The Motley Fool
Nov-14-22 02:34AM One Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatments MarketWatch
11:47AM Top Stock Reports for Chevron, Eli Lilly & Charles SchwabZacks Investment Research
Nov-14-22 07:16AM Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In FocusBenzinga
03:33AM Did You Buy And Not Sell Friday? You're Doing It Wrong - AgainSeeking Alpha
Nov-12-22 11:08AM Twitter Blue Account Declares Eli Lilly Giving Away Free Insulin, Pharma Giant Says Its FakeBenzinga
Nov-10-22 08:53AM Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11Benzinga
Nov-08-22 09:37AM 2 Powerhouse Dividend Stocks to Invest in This MonthThe Motley Fool
09:00AM Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Nov-07-22 02:07AM ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View UpZacks Investment Research
07:34AM Block, Eli Lilly And 2 Other Stocks Insiders Are SellingBenzinga
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; and Dicerna Pharmaceuticals, Inc., as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Cap:    |  Volume (24h):